Fixed drug eruption to piroxicam. Positive patch tests with cross-sensitivity to tenoxicam

Journal of Dermatological Treatment

Volumn 10, Issue 3, 1999, Pages 209-212

  Oliveira, H S ^a   Goncalo M ^a   Reis, J P ^a   Figueiredo, A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Cross sensitivity; Fixed drug eruption; Piroxicam; Positive lesional patch test; Tenoxicam; Thiosalicylic acid

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TENOXICAM; THIOSALICYLIC ACID;

ADULT; ARTICLE; CASE REPORT; CROSS REACTION; DRUG ERUPTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PATCH TEST; PHOTOSENSITIVITY; PRIORITY JOURNAL;

EID: 0345035262     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909056032     Document Type: Article

References (17)

1. Valsecchi R, Cainelli T, Nonpigmenting fixed drug reaction to piroxicam. J Am Acad Dermatol (1989) 21: 1300.
2. Stubb S, Reitamo S, Fixed drug eruption caused by piroxicam. J Am Acad Dermatol (1990) 22: 1111-12.
3. Hoz B de la, Soria C, Fraj J et al, Fixed drug eruption due to piroxicam. Int J Dermatol (1990) 29: 672-3.
4. Gastaminza G, Echechipia S, Navarro JA, Fernandez de Corres L, Fixed drug eruption from piroxicam. Contact Dermatitis (1993) 28: 43-4.
5. Ordoqui E, Barrio M de, Rodriguez VM et al, Cross-sensitivity among oxicams in piroxicam-caused fixed drug eruption: two case reports. Allergy (1995) 50: 741-4.
6. Baker H, Fixed eruption due to iodide and antipyrine. Br J Dermatol (1962) 74: 310-16.
7. Alanko K, Stubb S, Reitamo S, Topical provocation of fixed drug eruption. Br J Dermatol (1987) 116: 561-7.
8. Alanko K, Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis (1994) 31: 25-7.
9. Gonçalo M, Figueiredo A, Tavares P et al, Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam. Contact Dermatitis (1992) 27: 287-90.
10. La Cuadra J de, Pujol C, Aliaga A, Clinical evidence of cross-sensitivity between thiosalicylic acid, a contact allergen, and piroxicam, a photoallergen. Contact Dermatitis (1989) 21: 349-51.
11. Figueiredo A, Gonçalo M, Tavares P et al, Pathophysiology of photosensitivity to piroxicam. J Eur Acad Dermatol Venereol (1995) 5: 90.
12. Hindsén M, Christensen O, Gruic V, Löfberg H, Fixed drug eruption: an immunohistochemical investigation of the acute and healing phase. Br J Dermatol (1987) 116: 351-60.
13. Visa K, Kayhko K, Stubb S, Reitamo S, Immunocompetent cells of fixed drug eruption. Acta Derm Venereol (1987) 67: 30-5.
14. Shiohara T, Moriya N, Epidermal T cells: their functonal role and disease relevance for dermatologists. J Invest Dermatol (1997) 109: 271-5.
15. Smolle J, HLA-DR-antigen bearing keratinocytes in various dermatologic disorders. Acta Derm Venereol (1985) 65: 9-13.
16. Smolle J, Soyer HP, Juettner FM et al, HLA-DR-positive keratinocytes are associated with suppressor lymphocyte epidermotropism. A biomathematical study. Am J Dermatopathol (1988) 10: 128-32.
17. Shiohara I, What is new in fixed drug eruption. Dermatology (1995) 191: 185-7.